Nello Mainolfi

Company: Kymera Therapeutics
Job title: Founder, President & Chief Executive Officer
Seminars:
Targeted Protein Degradation Beyond Oncology 9:00 am
Advancing understanding and impact of TPD beyond existing E3 ligases What is needed to build programs beyond oncology IRAK4 degrader programs in immunologyRead more
day: Day Two